Literature DB >> 14739398

Selectins facilitate carcinoma metastasis and heparin can prevent them.

Lubor Borsig1.   

Abstract

Selectins are cell adhesion molecules mediating attachment of leukocytes to activated endothelium as well as the adhesion reaction of tumors during malignancy. Heparin, which is known to attenuate metastasis, is a potent blocker of selectins. Here, the role of selectins in metastasis and the potential of heparin to modulate malignancy are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14739398     DOI: 10.1152/nips.01450.2003

Source DB:  PubMed          Journal:  News Physiol Sci        ISSN: 0886-1714


  24 in total

1.  Exercise affects platelet-promoted tumor cell adhesion and invasion to endothelium.

Authors:  Yu-Wen Chen; Jan-Kan Chen; Jong-Shyan Wang
Journal:  Eur J Appl Physiol       Date:  2008-11-08       Impact factor: 3.078

Review 2.  Aptamers in immunotherapy.

Authors:  Claudia M Dollins; Smita Nair; Bruce A Sullenger
Journal:  Hum Gene Ther       Date:  2008-05       Impact factor: 5.695

3.  Knockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesion.

Authors:  Xiaoyan Yin; Kuldeepsinh Rana; Varun Ponmudi; Michael R King
Journal:  Carbohydr Res       Date:  2010-07-21       Impact factor: 2.104

4.  Antiangiogenic effect of bile acid acylated heparin derivative.

Authors:  Kyeongsoon Park; Yoo-Shin Kim; Gee Young Lee; Ju-Ock Nam; Seok Ki Lee; Rang-Woon Park; Sang Yoon Kim; In-San Kim; Youngro Byun
Journal:  Pharm Res       Date:  2006-11-16       Impact factor: 4.200

Review 5.  Non-anticoagulant heparins and inhibition of cancer.

Authors:  Benito Casu; Israel Vlodavsky; Ralph D Sanderson
Journal:  Pathophysiol Haemost Thromb       Date:  2009-01-27

6.  Inhibition of osteolytic bone metastasis by unfractionated heparin.

Authors:  Colin K Yee; Martin Butcher; Melec Zeadin; Jeffrey I Weitz; Stephen G Shaughnessy
Journal:  Clin Exp Metastasis       Date:  2008-09-24       Impact factor: 5.150

7.  Combination therapy of heparin-deoxycholic acid conjugate and doxorubicin against squamous cell carcinoma and B16F10 melanoma.

Authors:  Kyeongsoon Park; Gee Young Lee; Rang-Woon Park; In-San Kim; Sang Yoon Kim; Youngro Byun
Journal:  Pharm Res       Date:  2007-07-11       Impact factor: 4.200

8.  Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow.

Authors:  Susan N Thomas; Fei Zhu; Ronald L Schnaar; Christina S Alves; Konstantinos Konstantopoulos
Journal:  J Biol Chem       Date:  2008-03-27       Impact factor: 5.157

9.  Emodin-Loaded PLGA-TPGS Nanoparticles Combined with Heparin Sodium-Loaded PLGA-TPGS Nanoparticles to Enhance Chemotherapeutic Efficacy Against Liver Cancer.

Authors:  Hongyan Liu; Hong Xu; Chenghong Zhang; Meng Gao; Xiaoguang Gao; Chuchu Ma; Li Lv; Dongyan Gao; Sa Deng; Changyuan Wang; Yan Tian
Journal:  Pharm Res       Date:  2016-08-10       Impact factor: 4.200

10.  Pharmacological profiles of animal- and nonanimal-derived sulfated polysaccharides--comparison of unfractionated heparin, the semisynthetic glucan sulfate PS3, and the sulfated polysaccharide fraction isolated from Delesseria sanguinea.

Authors:  Inken Groth; Niels Grünewald; Susanne Alban
Journal:  Glycobiology       Date:  2008-12-23       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.